10 years of denosumab treatment in postmenopausal women with osteoporosis: results from the phase 3 randomised FREEDOM trial and open-label extension
Henry G. Bone(University of Michigan), Rachel B. Wagman(Amgen (United States)), Maria Luisa Brandi(University of Florence), Jacques P. Brown(Quebec Research and Development Centre), Roland Chapurlat(Université Claude Bernard Lyon 1), Steven R. Cummings, E. J. Czerwiński(Krakow Cardiovascular Research Institute), Astrid Fahrleitner‐Pammer(Medical University of Graz), David L. Kendler(University of British Columbia), Kurt Lippuner(University Hospital of Bern), Jean‐Yves Reginster(University of Liège), Christian Roux(Délégation Paris 5), Jorge Malouf(Hospital de Sant Pau), Michelle N. Bradley(Amgen (United States)), Nadia Daizadeh(Amgen (United States)), Andrea Wang(Amgen (United States)), Paula Dakin(Amgen (United States)), Nicola Pannacciulli(Amgen (United States)), David W. Dempster(Helen Hayes Hospital), Socrates E. Papapoulos(Leiden University Medical Center)
Cited by 954Open Access
Abstract
Related Papers
No related papers found
Powered by citation graph analysis